- CH₣261.15m
- CH₣182.27m
- CH₣84.59m
- 89
- 49
- 27
- 55
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 103 | 109 | 143 | 108 | 84.6 |
Cost of Revenue | |||||
Gross Profit | 102 | 109 | 141 | 104 | 81.8 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 74.8 | 77.3 | 89 | 76.7 | 64.5 |
Operating Profit | 27.9 | 31.9 | 53.6 | 31.2 | 20 |
Net Income Before Taxes | 27.9 | 31.9 | 53.6 | 31.2 | 20 |
Provision for Income Taxes | |||||
Net Income After Taxes | 19.5 | 23 | 43.1 | 25.3 | 15.2 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 14 | 22.3 | 43.1 | 25.3 | 15.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 14 | 22.3 | 43.1 | 25.3 | 15.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.89 | 2.24 | 3.41 | 1.9 | 1.15 |
Dividends per Share |